The Five Best Performing Stocks From Monday
The market had an impressive day proving that the Santa Claus rally may be in the works, but there were some under-the-radar stocks that posted even bigger gains Monday.
Here are the top five biggest gainers with share prices above $3.00:
Dynamics Research Corp. (NASDAQ: DRCO)
The company closed 58 percent higher after Engility Corp. announced that it was acquiring the Dynamics for $11.50 per share—a 59 percent premium over Dynamics’ Friday closing price of $7.25. The deal is expected to close during the first half of 2014.
United Therapeutics Corporation (NASDAQ: UTHR)
United Therapeutics closed 30 percent higher Monday after it announced after the bell Friday that the Food and Drug Administration had approved Orenitram, its oral treatment for pulmonary arterial hypertension. This is the fifth indication for PAH it has received and could set it up as the go-to drug maker for this condition.
Xyratex Ltd. (NASDAQ: XRTX)
The stock was up about 27 percent Monday after Seagate Technology agreed to acquire the company specializing in hard disk technology for $374 million—a 27 percent premium over the company’s Friday close. Seagate is trying to strengthen its supply chain and expand its storage portfolio. According to the release, the acquisition should add between $500 and $600 million to its 2015 revenue.
YRC Worldwide (NASDAQ: YRCW)
The company was up nearly 22 percent after it announced that it had negotiated an agreement that would allow it to refinance its debt and cut its interest payments by as much as one-third. Cutting $30 to $50 million from its current $150 per year interest payments hinges on a union vote set to take place next month.
Meritor (NASDAQ: MTOR)
Shares of Meritor, an integrated systems and components manufacturer serving the transportation industry was up 18 percent after a Morgan Stanley research note indicated that it received a favorable ruling from a Delaware District Court. According to the note, Eaton’s request for a pre-trial motion of judgment was being denied.
Disclosure: At the time of this writing, Tim Parker had no position in the mentioned stocks.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.